DCVax-L; autologous dendritic cell vaccine
Jump to navigation
Jump to search
Indications
- glioblastoma, adjunct to standard therapy
Adverse effects
- similar to standard therapy
More general terms
References
- ↑ Liau LM, Ashkan K, Tran DD et al First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 2018. 16:142 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29843811 Free PMC Article https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6